Rexahn Pharmaceuticals Inc (NYSE American:RNN)

2.17
Delayed Data
As of 2:27pm ET
 -0.111 / -4.87%
Today’s Change
1.42
Today|||52-Week Range
4.37
+7.38%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Suzdak Peter David
Chief Executive Officer
Gift8/16/201710,000$1.99$19.9K+16.92%
Suzdak Peter David
Chief Executive Officer
Buy2/28/20186,250$0.00$0.00+42.50%
Benaim Ely
Chief Medical Officer
Buy2/28/20182,375$0.00$0.00+42.50%
Nolan Lisa M
Chief Business Officer
Buy2/28/20181,625$0.00$0.00+42.50%